KANSAS KORAN: Open Payments
NPI 1891107447 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 21 payments from 11 companies in 2025. Trend: 2023 $553 · 2024 $484 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $219 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Travere Therapeutics, Inc. | 2 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| AKEBIA THERAPEUTICS INC | 1 | $17 |
Products named: Fabhalta, TERLIVAZ, LUPKYNIS, FUROSCIX, VELPHORO, IBSRELA, JYNARQUE, Vafseo.
Industry payments across SC — which companies pay providers there.
